Seasonal influenza vaccine value proposition: Development of a generic use case analytical framework and validation of use cases and country archetypes

MMGH is supporting the US CDC and WHO to validate preliminary use cases and country archetypes previously developed for seasonal influenza vaccines. MMGH is conducting staekholder surveys, interviews and workshops with global influenza experts to validate the use cases and country archetypes for seasonal influenza vaccines developed in the earlier project. These activities are also supporting the development of an analytical framework that is applicable to any influenza vaccine profile (e.g., next-generation and universal influenza vaccines). The project will help to support the full value of seasonal influenza vaccine assessment, including key market dynamics analayses and roadmaps and action plans for current and future seasonal influenza vaccine use.